Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-007666
Filing Date
2026-01-08
Accepted
2026-01-08 16:05:12
Documents
1
Period of Report
2026-01-06

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3688
  Complete submission text file 0001193125-26-007666.txt   5151
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 6W CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 6W CAMBRIDGE MA 02142 617-682-0917
Amylyx Pharmaceuticals, Inc. (Issuer) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMYLYX PHARMACEUTICALS, INC. 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address
Cohen Joshua B (Reporting) CIK: 0001898644 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41199 | Film No.: 26519618